Impact of implementing preanalytical laboratory standards on the diagnosis of gestational diabetes mellitus: A Prospective observational study

Clinical Chemistry

Volumn 62, Issue 2, 2016, Pages 387-391

  Daly, Niamh ^a   Flynn, Iseult ^a   Carroll, Ciara ^a   Farren, Maria ^a   Mckeating, Aoife ^a   Turner, Michael J ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; DIET RESTRICTION; FEMALE; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PHLEBOTOMY; PRACTICE GUIDELINE; PREGNANCY DIABETES MELLITUS; PROSPECTIVE STUDY; BLOOD SAMPLING; DIABETES, GESTATIONAL; GLUCOSE TOLERANCE TEST; PREGNANCY; STANDARDS;

BLOOD SPECIMEN COLLECTION; DIABETES, GESTATIONAL; FEMALE; GLUCOSE TOLERANCE TEST; GUIDELINES AS TOPIC; HUMANS; PREGNANCY; PROSPECTIVE STUDIES;

EID: 84957079954     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2015.247478     Document Type: Article

References (30)

1. O'Sullivan JB, Mahan CM. Criteria for the oral glucose tolerance test in pregnancy. Diabetes 1964;13:278 - 85.
2. Pedersen J. The pregnant diabetic and her newborn: problems and management. Baltimore (MD): William& Wilkins; 1967. p 128 -37.
3. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982; 144:768 -73.
4. HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovirindr U, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991-2002.
5. Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Aktary WM, et al. (University of Alberta Evidence-based Practice Center). Screening and diagnosing gestational diabetes mellitus. Rockville (MD): Agency for Healthcare Research and Quality. 2012 Oct. Contract No.: 290-2007-10021-I. AHRQ Publication No.: 12(13)-E021-EF. (Evidence report/technology assessment; no. 210). Available from: www.effectivehealthcare.ahrq.gov/reports/final.cfm. (Accessed January 2016).
6. Buckley BS, Harreiter J, Damm P, Corcoy R, Chico A, Simmons D, et al. Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review. Diabet Med 2012;29:844-54.
7. Turner MJ, Rasmussen MJ, Turner JE, Boylan P, MacDonald D, Stronge JM. The influence of birth weight on labor in nulliparas. Obstet Gynecol 1990;76:159 - 63.
8. Stotland NE, Caughey AB, Breed EM, Escobar GJ. Risk factors and obstetric complications associated with macrosomia. Int J Gynaecol Obstet 2004;87:220 - 6.
9. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005;352:2477- 86.
10. Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009;361:1339 - 48.
11. Lee AJ, Hiscock RJ, Wein P, Walker SP, and Permezel M. cohort study Gestational diabetes mellitus: clinical predictors and long-term risk of developing type 2 diabetes: A retrospective using survival analysis. Diabetes Care 2007;30:878 - 83.
12. Lehnen H, Zechner U, Haaf T. Epigenetics of gestational diabetes mellitus and offspring health: The time for action is in early life. Mol Human Reprod 2013;19:415- 22.
13. International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676 - 82.
14. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. Geneva: WHO; 2013. http://www.ncbi.nlm.nih.gov/pubmed/24199271 (Accessed October 2014).
15. Ali FM, Farah N, O'Dwyer V, O'Connor C, Kennelly MM, Turner MJ. The impact of new national guidelines on screening for gestational diabetes mellitus. Ir Med J 2013;106:57-9.
16. Langer O, Umans J, Miodovnik M. Perspectives on the proposed gestational diabetes mellitus diagnostic criteria. Obstet Gynecol 2013;121:177- 82.
17. Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care 2011;34: 61-99.
18. Daly N, Stapleton M, O'Kelly R, Kinsley B, Daly S, Turner MJ. The role of preanalytical glycolysis in the diagnosis of gestational diabetes mellitus in obese women. Am J Obstet Gynecol 2015;213:84.e1-5.
19. Dixon JB, O'Brien PE. Obesity and the white cell count: changes with sustained weight loss. Obes Surg 2006; 16:251-7.
20. Ladenson JH. Nonanalytical sources of variation in clinical chemistry results. In: Sonnenwith A, Jaetr L, editors. Clinical laboratory methods and diagnosis. St. Louis, MO: CV Mosby; 1980:149 -92.
21. Guidelines for the management of pre-gestational and gestational diabetes mellitus from pre-conception to the postnatal period: changing practice to support service delivery. Health Service Executive. http://www.hse.ie/eng/about/Who/clinical/natclinprog/obsandgynaeprogramme/guide11.pdf (Accessed October 2014).
22. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
23. Harlass FE, Brady K, Read JA. Reproducibility of the oral glucose tolerance test in pregnancy. Am J Obstet Gynecol 1991;164:564 - 8.
24. Catalano PM, Avallone DA, Drago NM, Amini SB. Reproducibility of the oral glucose tolerance test in pregnant women. Am J Obstet Gynecol. 1993;169:874 - 81.
25. Chan AYW, Swaminathan R, Cockram CS. Effectiveness of sodium fluoride as a preservative of glucose in blood. Clin Chem 1989;35:315-7.
26. Bruns DA, Knowler WC. Stabiliziation of glucose in blood samples: why it matters. Clin Chem 2009;55: 850 -2.
27. Stahl M, Jorgensen LG, Hyltoft Petersen P, Brandslund I, de Fine Olivarius N, Borch-Johnsen K. Optimization of preanalytical conditions and analysis of plasma glucose. 1. Impact of the new WHO and ADA recommendations on diagnosis of diabetes mellitus. Scand J Clin Lab Invest. 2001;61:169 -79.
28. del Pino IG, Constanso I, Mourín LV, Safont CB, Vázquez PR. Citric/citrate buffer: An effective antiglycolytic agent. Clin Chem Lab Med 2013;51:1943-9.
29. Festa R, Carta M, Ceriello A, Testa R. Time is glucose, can't miss gestational diabetes. Diabetes Technol Ther 2012;14:444 - 6.
30. Sacks DB. Diagnosis of gestational diabetes mellitus: it is time for international consensus? Clin Chem 2014; 60:141-3.